Heptares Collaboration With AstraZeneca Yields New Insights to Advance Drug Discovery in Pain, Cancer and Inflammation

http://ift.tt/eA8V8J
LONDON, April 27, 2017 /PRNewswire/ —
Novel mechanisms of action highlighted from resolved structures of PAR2 bound to antagonist molecules – research published in Nature
Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei Group Corporation (TSE Mothers…

April 27, 2017 at 12:18PM

http://ift.tt/2oyYzOo

from

http://ift.tt/2oyYzOo